Skip to main content

US ClosedU.S. Closed

ACRV: Acrivon Therapeutics, Inc. Common Stock Stock Analysis | finqOS

Healthcare · Biotechnology

Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments.

52W Range

34thpctl

Volume

0.42×avg

Market Cap

88.17MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Acrivon Therapeutics, Inc. Common Stock

ACRVNASDAQ Global Market·USD·Closed

Acrivon Therapeutics, Inc. Common Stock

ACRVNASDAQ·USD·Closed

$2.06

−4.19%

$2.06

−$0.09 (4.19%)

52W Range

34thpctl

Volume

0.42×avg

Mkt Cap

88.17MUSD

P/E

-1.1TTM

Div Yield

–ann